Virus-like Particle (VLP) Vaccine GMP Manufacturing

• Explained

  How Do VLP Vaccines Manufacture This process can be as little as scientists shoving proteins and DNA together in a big vat, more or less. These proteins and DNA are essentially the materials that help make up this virus-like shell. After that, they dump the tiny shells in virus-like shapes from machines. Specific equipment requirements, precise attention to detail for proper execution.

• The Manufacturing Process of VLP Vaccines

  Once the shells are created, scientists put some things in that help your body know how to fight germs. These extra ingredients are crucial as they educate your immune system. The shells wind up in vials, tiny bottles from which they are dispatched as vaccines. This means that the vaccine is delivered containing exactly enough of the VLP so that humans will be able to develop protection when they receive it.

• VLP Vaccines and the Future of Infectious Disease Prevention

  ///VLPs may not be perfect, but that does stop scientists looking to weaponize them. They want to ensure their own safety, as well the functioning of them in keeping individuals healthy. VLP technology and GMP enable us to produce safe, effective vaccines. As we find out more about preventing illness, studies like these are essential to optimizing the vaccines.

Why choose Yaohai Virus-like Particle (VLP) Vaccine GMP Manufacturing?

• Professional Expertise & Extensive Experience

  Yaohai Bio-Pharma is a leading Microbial biologics CDMO. We have been focused on microbial-produced therapeutics and vaccines for human, veterinary, and the management of pet health. We are equipped with Virus-like Particle (VLP) Vaccine GMP Manufacturing RD platforms as well as manufacturing technology that encompass the entire process beginning with the development of microbial strains cells, methods and processes, to commercial and clinical manufacturing which ensures successful implementation of cutting-edge solutions. We have acquired a large amount of experience in bio processing of microbial cells. We have delivered over 200 global projects, and help our clients with navigating the laws from the US FDA, EU EMA, Australia TGA, and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide tailored CDMO services.

• Customization, Efficiency & Cost-Effectiveness

  Yaohai Bio-Pharma has experience in the production of biologics created from Virus-like Particle (VLP) Vaccine GMP Manufacturing. We offer customized RD and manufacturing solutions while making sure that there are no risks. We have been involved in diverse modalities such as subunit vaccines recombinant, peptides hormones, cytokines, growth factors, single-domain antibodies enzymes, plasmid DNA MRNA, and many more. We are a specialist in many microorganisms, including yeast extracellular and intracellular secretion (yields up to 15g/L) as well as bacteria intracellular soluble and inclusion body (yields as high as 10g/L). We have also created a BSL-2 fermentation platform to create bacterial vaccines. We focus on improving processes, increasing product yields, and reducing production costs. Utilizing a strong technology team, we can ensure prompt and reliable project delivery that will bring your product to market faster.

• Robust Supply Chain & Manufacturing Capabilities

  Virus-like Particle (VLP) Vaccine GMP Manufacturing is a Top 10 biotech company specializing in microbiological fermentation. We have built a modern facility with strong RD capabilities and modern manufacturing facilities. Five production lines for pharmaceuticals in line with GMP standards for microbial purification and fermentation along with two automated fill and finish lines for vials and cartridges and pre-filled needles are available. The fermentation scales available are 100L, 500L, 1000L, to 2000L. Specifications for filling vials range from 1ml up to 25ml. the pre-filled syringes and cartridge filling specifications cover between 1-3ml. The workshop for production is cGMP compliant, and guarantees a stable supply of commercial products and clinical samples. Our factory produces large molecules that are shipped around the world.

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma, a top 10 Microbial CDMO that integrates quality management and regulatory affairs. Our quality system that is compliant with current GMP standards as well as international regulations. Our team of regulatory experts is proficient in global regulatory frameworks to accelerate biological launches. We ensure traceable production procedures quality products, as well as conformity with the requirements of the Virus-like Particle (VLP) Vaccine GMP Manufacturing and EU EMA. Australia TGA and China NMPA are also met. Yaohai BioPharma successfully passed an in-person audit conducted by a Qualified Person of the European Union (QP) to examine our GMP system and production facility. We also completed the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

Related product categories

Not finding what you're looking for?
Contact our consultants for more available products.